Structural Heart Devices Market Expansion 2024-2033: Growth Drivers and Dynamics

The structural heart devices global market report 2024 from The Business Research Company provides comprehensive market statistics, including global market size, regional shares, competitor market share, detailed segments, trends, and opportunities. This report offers an in-depth analysis of current and future industry scenarios, delivering a complete perspective for thriving in the industrial automation software market.

Structural Heart Devices Market, 2024 report by The Business Research Company offers comprehensive insights into the current state of the market and highlights future growth opportunities.

Market Size –
The structural heart devices market size has grown strongly in recent years. It will grow from $9.5 billion in 2023 to $10.4 billion in 2024 at a compound annual growth rate (CAGR) of 9.5%.  The  growth in the historic period can be attributed to the shift towards less invasive surgical techniques, the demand for minimally invasive structural heart devices, ongoing training and education programs for healthcare professionals, rising healthcare expenditure, growing patient preference for non-surgical or minimally invasive treatment options.

The structural heart devices market size is expected to see strong growth in the next few years. It will grow to $15.06 billion in 2028 at a compound annual growth rate (CAGR) of 9.7%.  The growth in the forecast period can be attributed to the increasing aging population, growing awareness about heart health, the implementation of screening programs, favorable reimbursement policies for structural heart procedures, timely regulatory approvals for new structural heart devices. Major trends in the forecast period include increasing adoption of transcatheter valve replacement, ongoing development of innovative devices with advanced materials, growing emphasis on personalized treatment approaches, increasing adoption of hybrid procedures, integration of remote monitoring and telehealth solutions.

Order your report now for swift delivery @
https://www.thebusinessresearchcompany.com/report/structural-heart-devices-global-market-report

Scope Of Structural Heart Devices Market
The Business Research Company’s reports encompass a wide range of information, including:
1. Market Size (Historic and Forecast): Analysis of the market’s historical performance and projections for future growth.
2. Drivers: Examination of the key factors propelling market growth.
3. Trends: Identification of emerging trends and patterns shaping the market landscape.
4. Key Segments: Breakdown of the market into its primary segments and their respective performance.
5. Focus Regions and Geographies: Insight into the most critical regions and geographical areas influencing the market.
6. Macro Economic Factors: Assessment of broader economic elements impacting the market.

Structural Heart Devices Market Overview

Market Drivers –
The rising prevalence of cardiovascular diseases is expected to propel the growth of the structural heart device market going forward. Cardiovascular diseases (CVDs) are a group of disorders affecting the heart and blood vessels, including conditions such as coronary artery disease, heart attacks, and strokes. The cases of cardiovascular diseases, including heart disease and stroke, have been steadily increasing globally due to sedentary lifestyles, poor dietary habits, rising obesity rates, smoking, and aging populations. Structural heart devices treat cardiovascular diseases by repairing or replacing damaged heart valves, correcting structural defects, and improving heart function and patient outcomes. For instance, in January 2024, according to a report published by the American Heart Association, a US-based nonprofit organization focused on cardiovascular medical research, cardiovascular disease caused 931,578 deaths in the US, slightly more than the 928,741 in 2020. Globally, there were 19.91 million CVD deaths in 2021, compared to 19.05 million in 2020. Therefore, the rising prevalence of cardiovascular diseases is driving the growth of the structural heart device market.

Market Trends –
Major companies operating in the structural heart devices market are developing minimally invasive treatment procedures and devices to enhance patient outcomes, reduce recovery times, and expand treatment options for structural heart conditions. A self-expanding transcatheter aortic valve implantation (TAVI) system is a device designed to deploy and secure the replacement valve within the native aortic valve anatomy without relying on balloon inflation. For instance, in December 2022, Abbott Laboratories, a US-based company manufacturing medical devices and health care products, launched the latest-generation transcatheter aortic valve implantation (TAVI) system, Navitor, in India. It is tailored for individuals with severe aortic stenosis at high or extreme surgical risk and features advancements such as a unique design to prevent valve leakage. Navitor enhances Abbott’s structural heart transcatheter portfolio, offering physicians and patients minimally invasive treatment options for heart diseases. It stands out as the sole self-expanding TAVI system with intra-annular leaflets and large frame cells, facilitating improved access to coronary arteries for potential future interventions in coronary artery disease (CAD). This new design also enhances hemodynamics, optimizing blood flow.

The structural heart devices market covered in this report is segmented –
1) By Type: Heart Valve Devices, Annuloplasty Rings, Occluders, Delivery Systems
2) By Procedure: Replacement Procedures, Repair Procedures
3) By Indication: Atrial Septal Defect, Patent Foramen Ovale, Ventricular Septal Defect, Aortic Valve Stenosis, Other Indications
4) By Age Group: Pediatric, Adults

Get an inside scoop of the structural heart devices market, Request now for Sample Report @
https://www.thebusinessresearchcompany.com/sample.aspx?id=15677&type=smp

Regional Insights –
North America was the largest region in the structural heart devices market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the structural heart devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Key Companies –
Major companies operating in the structural heart devices market are  Abbott Laboratories, Medtronic Plc, Boston Scientific Corporation, Terumo Corporation, Edwards Lifesciences Corporation, W. L. Gore & Associates Inc., Bracco Group, LivaNova PLC, Meril Life Sciences Pvt. Ltd., CryoLife Inc., Braile Biomédica, TTK Healthcare Limited, Direct Flow Medical Inc., JenaValve Technology Inc., Micro Interventional Devices Inc., CardioKinetix Inc., Xeltis AG, Ancora Heart Inc., JOMDD Inc., Valcare Medical, BioStable Science & Engineering Inc., Comed B.V., Transcatheter Technologies GmbH, Navilyst Medical Inc.

Table of Contents
1. Executive Summary
2. Structural Heart Devices Market Report Structure
3. Structural Heart Devices Market Trends And Strategies
4. Structural Heart Devices Market – Macro Economic Scenario
5. Structural Heart Devices Market Size And Growth
…..
27. Structural Heart Devices Market Competitor Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
30. Appendix

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model